Inhaled insulin drug Afrezza, from L.A.'s MannKind, is approved

June 27, 2014 9:36 PM

4 0

Los Angeles billionaire inventor Alfred Mann's almost decade-long quest to develop an inhalable form of insulin for diabetics won approval Friday from U.S. regulators.

His Valencia company, MannKind Corp., got the OK to sell the drug called Afrezza, although regulators warned the product shouldn’t be used by diabetics with asthma or a serious lung disease. The Food and Drug Administration said Friday it had cleared Afrezza for Type 1 and Type 2 diabetes.

Also read: AT&T-Time Warner deal sparks calls for scrutiny in Washington

Read more

To category page